BioCentury | Jun 1, 2015
Company News

Orexo deal

...maintenance treatment of opioid dependence. Orexo declined to disclose financial terms. Kibion markets breath tests Diabact UBT...
BioCentury | Jul 18, 2011
Company News

Orexo, Wagner Analysen Technik deal

...with a broader platform to develop and commercialize other diagnostic breath tests. Kibion markets its Diabact UBT...
BioCentury | Nov 21, 2005

Ebb & Flow

...profitable in the latter half of 2007 based on product revenues and royalties. ORX markets Diabact UBT...
BioCentury | Nov 15, 2005
Financial News

Orexo raises $40.9 million in IPO's proposed range of SEK90-SEK105. Joint-lead underwriters were Carnegie and ABG Sundal Collier. ORX markets Diabact UBT...
BioCentury | Mar 28, 2005
Company News

Orexo diagnostic news

...Orexo formed a subsidiary to commercialize Orexo's Diabact UBT , a breath test to diagnose Helicobacter pylori...
Items per page:
1 - 5 of 5